Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $716.26 | 9 | 86.7% |
| Education | $110.33 | 3 | 13.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $234.09 | 2 | $0 (2021) |
| ABBVIE INC. | $162.31 | 4 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $136.44 | 1 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $100.58 | 1 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $82.84 | 1 | $0 (2017) |
| Allergan Inc. | $61.49 | 2 | $0 (2019) |
| ITI, Inc. | $48.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.26 | 3 | ABBVIE INC. ($147.26) |
| 2023 | $15.05 | 1 | ABBVIE INC. ($15.05) |
| 2022 | $149.42 | 2 | Otsuka America Pharmaceutical, Inc. ($100.58) |
| 2021 | $109.09 | 1 | Janssen Pharmaceuticals, Inc ($109.09) |
| 2019 | $291.43 | 3 | Neurocrine Biosciences, Inc. ($136.44) |
| 2018 | $31.50 | 1 | Allergan Inc. ($31.50) |
| 2017 | $82.84 | 1 | Sunovion Pharmaceuticals Inc. ($82.84) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $116.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2022 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 02/17/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $100.58 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $109.09 | General |
| Category: Neuroscience | ||||||
| 08/15/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 04/17/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $136.44 | General |
| Category: NEUROLOGY | ||||||
| 02/21/2019 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/17/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $82.84 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 63 | 171 | $17,335 | $8,723 |
| 2022 | 2 | 81 | 190 | $17,903 | $10,069 |
| 2021 | 4 | 57 | 98 | $9,152 | $5,443 |
| 2020 | 4 | 103 | 132 | $12,493 | $4,661 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 30 | 80 | $9,600 | $5,143 | 53.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 33 | 91 | $7,735 | $3,580 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 33 | 79 | $9,138 | $5,054 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 48 | 111 | $8,765 | $5,016 | 57.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 25 | $2,775 | $1,997 | 72.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 29 | $2,175 | $1,540 | 70.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 14 | 23 | $2,627 | $959.18 | 36.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 16 | 21 | $1,575 | $946.51 | 60.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 21 | 39 | $4,366 | $2,166 | 49.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 27 | 32 | $3,552 | $1,106 | 31.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 19 | 25 | $1,875 | $1,028 | 54.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 36 | 36 | $2,700 | $360.98 | 13.4% |
About Dr. Rochelle Klinger, M.D
Dr. Rochelle Klinger, M.D is a Psychiatry healthcare provider based in Ashland, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508833682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rochelle Klinger, M.D has received a total of $826.59 in payments from pharmaceutical and medical device companies, with $147.26 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($716.26).
As a Medicare-enrolled provider, Klinger has provided services to 304 Medicare beneficiaries, totaling 591 services with total Medicare billing of $28,896. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Ashland, VA
- Active Since 03/07/2006
- Last Updated 10/10/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1508833682
Products in Payments
- VRAYLAR (Drug) $223.80
- INGREZZA (Drug) $136.44
- SPRAVATO (Drug) $125.00
- INVEGA SUSTENNA (Drug) $109.09
- ABILIFY MAINTENA (Drug) $100.58
- LATUDA (Drug) $82.84
- CAPLYTA (Drug) $48.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Ashland
Scott Lance, M.d, M.D
Psychiatry — Payments: $10,543
Dr. Manish Parikh, Md, MD
Psychiatry — Payments: $5,205
Frances Swarn, M.d, M.D
Psychiatry — Payments: $2,592
Anne Zappacosta, Md, MD
Psychiatry — Payments: $1,784
Brittany Richardson, Do, DO
Psychiatry — Payments: $1,316
Amber Wireman, Do, DO
Psychiatry — Payments: $1,193